Section 134000.

134000. For purposes of this division: (a) “ANDA” means abbreviated new drug application. (b) “ANDA filer” means a party that owns or controls an ANDA filed with the Food and Drug Administration or has the exclusive rights under that ANDA to distribute the ANDA product. (c) “Agreement” means anything that would constitute an agreement under California state law […]

Section 134002.

134002. (a) (1) Except as provided in paragraph (3), an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects and shall be a violation of this section if both of the following apply: (A) A nonreference drug […]